PMC:7228307 / 7902-8124 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"123","span":{"begin":57,"end":62},"obj":"Gene"},{"id":"124","span":{"begin":64,"end":72},"obj":"Gene"},{"id":"125","span":{"begin":203,"end":206},"obj":"Gene"},{"id":"134","span":{"begin":48,"end":55},"obj":"Gene"}],"attributes":[{"id":"A123","pred":"tao:has_database_id","subj":"123","obj":"Gene:2214"},{"id":"A124","pred":"tao:has_database_id","subj":"124","obj":"Gene:2214"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"Gene:613"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Gene:2212"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T71","span":{"begin":94,"end":98},"obj":"Body_part"},{"id":"T72","span":{"begin":123,"end":127},"obj":"Body_part"},{"id":"T73","span":{"begin":142,"end":150},"obj":"Body_part"},{"id":"T74","span":{"begin":181,"end":185},"obj":"Body_part"}],"attributes":[{"id":"A71","pred":"fma_id","subj":"T71","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A72","pred":"fma_id","subj":"T72","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A73","pred":"fma_id","subj":"T73","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A74","pred":"fma_id","subj":"T74","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T127","span":{"begin":48,"end":50},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T128","span":{"begin":57,"end":59},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T129","span":{"begin":64,"end":66},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T130","span":{"begin":92,"end":98},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T131","span":{"begin":123,"end":127},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T132","span":{"begin":128,"end":138},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T133","span":{"begin":181,"end":185},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T134","span":{"begin":186,"end":196},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T135","span":{"begin":211,"end":221},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T33","span":{"begin":60,"end":62},"obj":"Chemical"}],"attributes":[{"id":"A33","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_73814"},{"id":"A34","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_8753"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T50","span":{"begin":94,"end":98},"obj":"http://purl.obolibrary.org/obo/CL_0000000"},{"id":"T51","span":{"begin":123,"end":127},"obj":"http://purl.obolibrary.org/obo/CL_0000000"},{"id":"T52","span":{"begin":181,"end":185},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"123","span":{"begin":57,"end":62},"obj":"Gene"},{"id":"124","span":{"begin":64,"end":72},"obj":"Gene"},{"id":"125","span":{"begin":203,"end":206},"obj":"Gene"},{"id":"134","span":{"begin":48,"end":55},"obj":"Gene"}],"attributes":[{"id":"A123","pred":"pubann:denotes","subj":"123","obj":"Gene:2214"},{"id":"A124","pred":"pubann:denotes","subj":"124","obj":"Gene:2214"},{"id":"A125","pred":"pubann:denotes","subj":"125","obj":"Gene:613"},{"id":"A134","pred":"pubann:denotes","subj":"134","obj":"Gene:2212"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T70","span":{"begin":94,"end":98},"obj":"Body_part"},{"id":"T71","span":{"begin":123,"end":127},"obj":"Body_part"},{"id":"T72","span":{"begin":142,"end":150},"obj":"Body_part"},{"id":"T73","span":{"begin":181,"end":185},"obj":"Body_part"}],"attributes":[{"id":"A70","pred":"fma_id","subj":"T70","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A71","pred":"fma_id","subj":"T71","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A72","pred":"fma_id","subj":"T72","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A73","pred":"fma_id","subj":"T73","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T28","span":{"begin":92,"end":112},"obj":"http://purl.obolibrary.org/obo/GO_0042100"},{"id":"T29","span":{"begin":94,"end":112},"obj":"http://purl.obolibrary.org/obo/GO_0008283"},{"id":"T30","span":{"begin":123,"end":138},"obj":"http://purl.obolibrary.org/obo/GO_0001775"},{"id":"T31","span":{"begin":181,"end":196},"obj":"http://purl.obolibrary.org/obo/GO_0001775"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T28","span":{"begin":92,"end":112},"obj":"http://purl.obolibrary.org/obo/GO_0042100"},{"id":"T29","span":{"begin":94,"end":112},"obj":"http://purl.obolibrary.org/obo/GO_0008283"},{"id":"T30","span":{"begin":123,"end":138},"obj":"http://purl.obolibrary.org/obo/GO_0001775"},{"id":"T31","span":{"begin":181,"end":196},"obj":"http://purl.obolibrary.org/obo/GO_0001775"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T28","span":{"begin":92,"end":112},"obj":"http://purl.obolibrary.org/obo/GO_0042100"},{"id":"T29","span":{"begin":94,"end":112},"obj":"http://purl.obolibrary.org/obo/GO_0008283"},{"id":"T30","span":{"begin":123,"end":138},"obj":"http://purl.obolibrary.org/obo/GO_0001775"},{"id":"T31","span":{"begin":181,"end":196},"obj":"http://purl.obolibrary.org/obo/GO_0001775"}],"text":"tation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa\nInhibition Reduce B‐cell proliferation or innate cell activation by antibody complexes Inhibition of ITAM cell activation (i.e. BCR) or activating‐"}